Tenofovir Disoproxil Fumarate Tablet
Product Images NDC 64380-714

2 FDA label images from Strides Pharma Science Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Tenofovir Disoproxil Fumarate (NDC 64380-714). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Strides Pharma Science Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (961e32f0 F1e2 4d34 Ba55 7cf8355c060d 01)

Image (961e32f0 F1e2 4d34 Ba55 7cf8355c060d 01)
Chemical structure of tenofovir disoproxil fumarate, the active ingredient in the TENOFOVIR DISOPROXIL FUMARATE 300 mg oral tablet by Strides Pharma Science Limited.*
FDA Label Image

Tenofovir Disoproxil Fumarate Tablets (961e32f0 F1e2 4d34 Ba55 7cf8355c060d 02)

Tenofovir Disoproxil Fumarate Tablets (961e32f0 F1e2 4d34 Ba55 7cf8355c060d 02)
Label for Tenofovir Disoproxil Fumarate Tablets 300 mg oral tablets by Strides Pharma Science Ltd. The label shows a 30 tablet package, dosage strength 300 mg, and includes storage instructions. Manufactured by Strides Pharma Science Ltd. in Bengaluru, India, and distributed by Strides Pharma Inc. in Bridgewater, NJ. The label also features NDC 64380-714-04 and space for batch details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.